 |
2022 More About MS: Achieving Health and Happiness While Living with Multiple SclerosisClick here to view the video |
 |
How to Care for LGBTQIA+ PatientsRead Article |
 |
Exercise Resource Guide for SeniorsRead Article |
 |
2022 Nightingale Awards:US Recipients2022 Nightingale Awards: |
 |
2021 More About MS: An Exploration of the MS Patient JourneyClick here to view the video |
 |
2021 Nightingale Awards:US Recipients2021 Nightingale Nurse Immersion Program:Participants |
|
2020 Nightingale Awards:Videos | Celebrating the 2020 International Year of the Nurse |
|
October 10, 2020 | Differing Perspectives on MS Nursing Care |
| APPROVED REPORT POSTED | T I T L E |
March 23, 2020
|
MS NursED Harnessing KnowledgeLiving Well with MS:
Tuesday - September 10, 2019 |
| DATE POSTED | T I T L E / A N N O U N C E M E N T |
February 15, 2017 |
WEBINAR: Betaconnect Device & Betaplus Program  Access Webinar Here |
| DATE POSTED | T I T L E / A N N O U N C E M E N T |
| October 20, 2016 |
Physical Activity and Cognitive Function in Adults with Multiple Sclerosis: An Integrative Review by Janet D. Morrison & Lori Mayer Published Online: October 20, 2016 Purpose: To identify and synthesize the research evidence concerning (1) the relationship between physical activity and cognitive performance in persons with multiple sclerosis (MS) and (2) to review the reported effects of physical activity interventions on neurocognitive performance conducted in this population. |
July 21, 2016 |
WEBINAR: Alemtuzumab Clinical Information for Nurses (LEMTRADA) Access Webinar Here |
| DATE POSTED | T I T L E / A N N O U N C E M E N T |
March 2014 - December 2015 |
WEBINAR: Caring for the Patient with MS Access Webinars Here |
| DATE POSTED | T I T L E / A N N O U N C E M E N T |
| August 2013 - May 2014 | WEBINAR: 2013-14 TOWN HALL DISCUSSIONS View Presentations (PDF) WEBINAR: 2013-14 TOWN HALL DISCUSSIONS: Access Webinars |
| October 14, 2014 |
FDA Perpmits Marketing of Urinary Prosthesis Device for Women Release Date: October 14, 2014 The U.S. Food and Drug Administration today allowed marketing of the inFlow Intraurethral Valve-Pump, a replaceable urinary prosthesis for use in female adults who cannot contract the muscles necessary to push urine out of the bladder (impaired detrusor contractility or IDC). |
| September, 2014 |
Acute Neurologic Illness with Focal Limb Weakness of Unknown Etiology in Children In September, the Centers for Disease Control and Prevention (CDC) issued a Health Advisory to healthcare professionals nationwide to be vigilant for and report cases of neurologic illnesses associated with limb weakness that meet the criteria of its case definition. |
| August, 2014 |
PEGYLATED INTERFERON BETA-1A (PLEGRIDY) – Clinician Information Generic: Peginterferon Beta-1a Brand name: Plegridy US FDA Approved: August 2014 |
| February 4, 2014 | Genzyme's Lemtrada Approved in Mexico for Treatment of MS On February 4, 2014, Genzyme, a Sanofi company, announced that Mexico’s national regulatory authority, COFEPRIS, has approved Lemtrada (alemtuzumab) for the treatment of patients with relapsing remitting forms of multiple sclerosis (MS) to slow or reverse the accumulation of physical disability and reduce the frequency of clinical exacerbations. |
| January 28, 2014 |
New Copaxone Dosing Approved for Fewer Injections
On January 28, 2014, Teva Pharmaceutical Industries Ltd. announced that the new, three-times-per-week dosing of Copaxone® (glatiramer acetate), at the more concentrated dose of 40 mg, has been approved by the FDA. |
| DATE POSTED | T I T L E / A N N O U N C E M E N T |
| May 2012 - May 2013 | PODCAST: 2012-13 TOWN HALL DISCUSSIONS View Presentations (PDF) PODCAST: 2012-13 TOWN HALL DISCUSSIONS: Listen to PODCAST |
| April 2012 |
Novartis Announces Update to GilenyaTM (fingolimod) U.S. Prescribing Information Following FDA Review Novartis Press Release: click here Gilenya Prescribing Information (PDF: 427KB) In addition, on April 20, 2012, the European Medicines Agency (EMA) issued a press release outlining changes to the recommended use of Gilenya in the European Union (Summary of Product Characteristics). These recommendations do not apply to the U.S. EMA Press Release: click here Summary of Product Characteristics (PDF: 384KB) |
| March 2012 | THE JANET PEARCE MS NURSE TRAINING PROGRAM March 23 and 24, 2012 (Friday and Saturday) The NYU Wasserman Center for Career Development 133 East 13th St. (between 3rd and 4th Avenues), 2/F New York, N.Y. 10003 8:30 a.m. – 4:30 p.m. (both days) This is the eighth conference of the Janet Pearce MS Nurse Training Program which began 10 years ago. For more information contact Andrea Arzt at 212-453-3215 or aarzt@msnyc.org. View Complete Program Information |
| March 2012 | THE 4TH ANNUAL LINDA MORGANTE MS NURSE LEADERSHIP PROGRAM This intensive, two-day course on contemporary topics in MS is led by faculty who are thought leaders in MS nursing. The program will be held Monday through Wednesday, May 28-30, 2012 at the Hilton San Diego Bayfront, immediately preceding the CMSC Annual Meeting in San Diego, California. To apply for the program you must be a nurse with an interest in MS who is based in the United States or Canada. Please complete the application to apply for the program. Space is limited to 40 nurses, apply by March 9, 2012! Please contact Katie at 877-444-8435 ext. 159 or if you have any questions. View Complete Program Information |
| DATE POSTED | T I T L E |
| Jan - Dec, 2011 | PODCAST: 2011 TOWN HALL DISCUSSIONS View Presentations (PDF) PODCAST: 2011 TOWN HALL DISCUSSIONS: Listen to PODCAST |
| March 17, 2011 | The Multiple Sclerosis Emerging Therapies Collaborative Launched View Article |
| DATE POSTED | T I T L E |
| September 22, 2010 | New Oral Medication for Multiple Sclerosis! Novartis gains FDA approval for Gilenya, a novel first-line MS treatment PDF: 132 KB |